Parameter | PFS | OS | ||||
---|---|---|---|---|---|---|
3-year | 5-year | P | 3-year | 5-year | P | |
Overall, % | 60.8 | 45.9 | Ā | 78.8 | 68.0 | Ā |
Age | Ā | Ā | 0.278 | Ā | Ā | 0.004 |
<60Ā years, % | 64.5 | 46.9 | Ā | 87.9 | 80.6 | Ā |
ā„60Ā years, % | 50.3 | 40.2 | Ā | 57.9 | 44.3 | Ā |
Sex | Ā | Ā | 0.634 | Ā | Ā | 0.410 |
Male, n (%) | 63.9 | 52.1 | Ā | 80.2 | 71.0 | Ā |
Female, n (%) | 53.4 | 44.8 | Ā | 71.9 | 61.4 | Ā |
B symptoms | Ā | Ā | 0.673 | Ā | Ā | 0.289 |
No, % | 62.5 | 52.4 | Ā | 80.5 | 74.3 | Ā |
Yes, % | 50.0 | 31.5 | Ā | 66.1 | 45.8 | Ā |
LDH | Ā | Ā | 0.011 | Ā | Ā | 0.018 |
Normal, % | 73.6 | 58.2 | Ā | 89.2 | 68.2 | Ā |
Elevated, % | 34.8 | 21.9 | Ā | 55.2 | 38.2 | Ā |
Lymph node involvement | Ā | Ā | 0.143 | Ā | Ā | 0.231 |
No, % | 66.8 | 60.0 | Ā | 81.4 | 75.1 | Ā |
Yes, % | 15.6 | 2.2 | Ā | 64.0 | 44.3 | Ā |
Bone marrow involvement | Ā | Ā | 0.719 | Ā | Ā | 0.319 |
No, % | 59.1 | 42.0 | Ā | 80.0 | 72.3 | Ā |
Yes, % | 72.9 | 72.9 | Ā | 54.9 | 42.0 | Ā |
Sites | Ā | Ā | 0.022 | Ā | Ā | 0.022 |
Appendicular, % | 66.7 | 51.1 | Ā | 78.4 | 70.6 | Ā |
Axial, % | 59.1 | 59.1 | Ā | 100.0 | 100.0 | Ā |
Both, % | 5.6 | 0 | Ā | 61.4 | 61.4 | Ā |
Number of bone sites | Ā | Ā | 0.001 | Ā | Ā | <0.001 |
Unifocal, % | 75.7 | 75.7 | Ā | 89.2 | 83.5 | Ā |
Multifocal, % | 36.8 | 13.4 | Ā | 53.1 | 36.7 | Ā |
Stage | Ā | Ā | 0.005 | Ā | Ā | 0.001 |
IE/IIE, % | 73.8 | 73.8 | Ā | 97.1 | 97.1 | Ā |
IVE, % | 43.0 | 18.0 | Ā | 58.5 | 49.8 | Ā |
CD10 | Ā | Ā | 0.267 | Ā | Ā | 0.077 |
Negative, % | 52.9 | 29.8 | Ā | 76.8 | 65.2 | Ā |
Positive, % | 64.4 | 55.2 | Ā | 95.7 | 95.7 | Ā |